Stock Report

All about this stock under one free report Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Adaptimmune Therapeutics (ADAP) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$0.04

up-down-arrow $0.01 (17.50%)

As on 03-Dec-2025 09:30EDT

Market cap

info icon

$15 Mln

Revenue (TTM)

info icon

$65 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2.7

Div. Yield

info icon

0 %

The underlying data is unavailable.
loading...
loading...